See more : Bodal Chemicals Limited (BODALCHEM.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Digital Health Acquisition Corp. (DHAC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Digital Health Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Beat Holdings Limited (9399.T) Income Statement Analysis – Financial Results
- Accor SA (AC.PA) Income Statement Analysis – Financial Results
- Enovis Corporation (ENOV) Income Statement Analysis – Financial Results
- Brait PLC (BAT.JO) Income Statement Analysis – Financial Results
- EISO Enterprise Co., Ltd. (5291.TWO) Income Statement Analysis – Financial Results
Digital Health Acquisition Corp. (DHAC)
About Digital Health Acquisition Corp.
Digital Health Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to focus on technology and healthcare focused businesses. The company was incorporated in 2021 and is based in Boca Raton, Florida.
| Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 |
| General & Administrative | 2.59M | 0.00 | 282.67K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 |
| SG&A | 2.59M | 3.59M | 282.67K |
| Other Expenses | 0.00 | 3.59M | 0.00 |
| Operating Expenses | 2.59M | 3.59M | 282.67K |
| Cost & Expenses | 2.59M | 3.59M | 282.67K |
| Interest Income | 358.77K | 922.64K | 2.63 |
| Interest Expense | 2.18M | 125.98K | 0.00 |
| Depreciation & Amortization | 167.90K | 922.64K | 1.97K |
| EBITDA | -2.59M | -3.59M | -282.67K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% |
| Operating Income | -2.59M | -3.59M | -282.67K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.82M | 539.69K | 1.97K |
| Income Before Tax | -4.41M | -3.06M | -280.70K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 187.23K | -1.97K |
| Net Income | -4.41M | -3.24M | -280.70K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% |
| EPS | -1.08 | -0.25 | -0.02 |
| EPS Diluted | -1.08 | -0.25 | -0.02 |
| Weighted Avg Shares Out | 4.10M | 12.74M | 14.93M |
| Weighted Avg Shares Out (Dil) | 4.10M | 12.74M | 14.93M |
Counterpart Health Names David Tsay M.D., Ph.D as Chief Medical Officer
Digital Health Acquisition Corp. Announce Closing of Business Combination Transaction
VivaWell and Shen.AI Announce Strategic Partnership to Transform Health Monitoring in Mexico and Argentina
Study at Japan's Kameda Medical Center Demonstrates Excellent Outcomes for Ibex's AI-powered Solution in Diagnosing Prostate and Breast Cancer
Comparing KONE Oyj (OTCMKTS:KNYJY) & Digital Health Acquisition (NASDAQ:DHAC)
Digital Health Acquisition Corp. Announces Listing Transfer to the Nasdaq Capital Market
Source: https://incomestatements.info
Category: Stock Reports